Becker’s Hospital Review: RCM company rebrands as Anka.

On May 6, 2026, Becker’s Hospital Review — the publication of record for hospital and health system executives — covered Anka’s rebrand from Jindal Healthcare and the company’s evolution into an AI-native execution platform for revenue cycle management. Writing for Becker’s Finance and Revenue Cycle Management vertical, journalist Andrew Cass reported on the company’s repositioning as an execution layer designed to automate denial management, underpayment recovery, and accounts receivable follow-up workflows for mid-market healthcare organizations, rural healthcare providers, and physician groups.

What Becker’s covered.

The Becker’s piece anchors on three threads. First, the structural shift: Anka is not another reporting dashboard but a platform that acts on the unworked AR sitting inside every hospital’s billing system. Second, the target market: mid-market providers, rural facilities, and independent physician groups — precisely the operators most exposed to automated payer denials and least equipped to absorb the administrative cost of fighting them. Third, the CEO’s framing of administrative burden as a clinical risk, not just a financial inconvenience.

The coverage appears in Becker’s Revenue Cycle Management section, the same vertical where most of the country’s RCM directors, revenue integrity leaders, and hospital CFOs go to keep current on the operating practices, vendor decisions, and policy shifts shaping their margins.

The CEO’s framing.

The Becker’s piece quotes Anka CEO Madhav Garg explaining why the company chose this name and this direction at this moment. The administrative burden, he argues, is no longer a back-office complaint — it’s a threat to clinical continuity.

The rebrand story.

For more than a decade, Jindal Healthcare ran one of the country’s largest RCM operations, managing the revenue cycles of 300+ providers — rural hospitals, physician groups, and specialty practices. The work was repeatable, predictable, and clearly automatable. But every vendor in the space sold the same thing: dashboards that flagged denials, scored risk, and predicted outcomes. None of them actually wrote the appeal, filed it, or tracked it through to resolution.

Anka — inspired by the ancient symbol for life — is the answer that team built once they ran out of options at scale. The platform sits on top of existing EHR and billing systems and autonomously resolves the AR that typically goes uncollected. The rebrand signals the company’s evolution from RCM operator to AI-native execution platform, now offered to other healthcare organizations as managed service, software, or both.

Platform benchmarks.

The performance numbers Anka shared with Becker’s come from live revenue cycle operations across the 300+ providers managed under the Jindal Healthcare banner — not projection models, not pilot studies.

• 68.4% overturn rate on complex, high-denial claims — industry-leading recovery on the work most operations walk away from.
• Under 2 minutes per appeal, down from 20 minutes of manual labor — a comprehensive, evidence-based filing in autonomous execution.
• End-to-end coverage across the 18.7% denial leak, the 11% underpayment leak, and the 32% of AR that ages past 90 days.

Why this coverage matters.

Becker’s reaches more than 500,000 healthcare executives — CFOs, RCM directors, revenue integrity leaders, hospital administrators. Its endorsement is significant not because Anka needs validation, but because the conversation about execution AI — vs. dashboards, copilots, and intelligence layers — moves further into the mainstream when the publication of record covers it directly.

The Becker’s coverage lands ahead of the 2026 IT + Revenue Cycle Conference in Chicago and the broader Medicaid redetermination cycle that’s putting rural hospital margins under structural pressure. For executives reading Becker’s daily, Anka now sits inside the consideration set for execution-grade RCM platforms.

What it signals for the industry.

The Becker’s piece reflects a category shift the RCM industry has been talking about quietly for two years: the move from observation to execution. Healthcare AI to date has been overwhelmingly observational — it surfaces denial trends, scores risk, predicts which accounts will age. Anka takes the next step by closing the work, not describing it.

For provider organizations evaluating their 2026 vendor strategy, the signal is clear. The platform isn’t competing with dashboards. It’s competing with the human work that dashboards point at — and shipping software that moves the cash conversion needle in days in AR, denial rate, net collection rate, and cost-to-collect, not in dashboard adoption metrics.